Page last updated: 2024-08-26

n-methyladenosine and Leukemia

n-methyladenosine has been researched along with Leukemia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Chen, TQ; Chen, YQ; Chen, ZH; Fang, K; Han, C; Huang, W; Luo, XQ; Sun, LY; Sun, YM; Wang, D; Wang, WT; Zeng, ZC1
Fatica, A; Fazi, F1
Batista, PJ; Schmiechen, AC1

Reviews

1 review(s) available for n-methyladenosine and Leukemia

ArticleYear
Regulation of Ribosome Function by RNA Modifications in Hematopoietic Development and Leukemia: It Is Not Only a Matter of m
    International journal of molecular sciences, 2021, Apr-30, Volume: 22, Issue:9

    Topics: Adenosine; Animals; Gene Expression Regulation, Leukemic; Humans; Leukemia; Ribosomes; RNA; RNA Processing, Post-Transcriptional; RNA, Messenger; RNA, Ribosomal; RNA, Transfer

2021

Other Studies

2 other study(ies) available for n-methyladenosine and Leukemia

ArticleYear
Nuclear export of chimeric mRNAs depends on an lncRNA-triggered autoregulatory loop in blood malignancies.
    Cell death & disease, 2020, 07-23, Volume: 11, Issue:7

    Topics: Active Transport, Cell Nucleus; Adenosine; Animals; Cell Line, Tumor; Cell Nucleus; Disease Progression; Gene Expression Regulation, Leukemic; Gene Rearrangement; Humans; Leukemia; Male; Methyltransferases; Mice, Inbred NOD; Mice, SCID; Models, Biological; Nerve Tissue Proteins; Oncogene Proteins, Fusion; RNA Splicing Factors; RNA, Long Noncoding; RNA, Messenger; Serine-Arginine Splicing Factors

2020
An epitranscriptomic vulnerability in myeloid malignancies.
    Nature medicine, 2017, 11-07, Volume: 23, Issue:11

    Topics: Adenosine; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Methyltransferases; Myeloproliferative Disorders; Neoplasms

2017